Molecular Interaction and Simulation Studies of Inhibitors for Endothelin-1 Receptors

Authors

  • P. Shanmughavel Department of Bioinformatics, Bharathiar University, Cbe-46, Tamil Nadu, India
  • Grace Ratna Roy Department of Bioinformatics, Karpagam University, Coimbatore, India

DOI:

https://doi.org/10.37591/(rrjobi).v2i3.389

Abstract

High altitude cerebral edema (HACE) is a life threatening severe form of acute mountain sickness (AMS) which causes headache, unbalanced gait, behavioral changes, and altered mental status. It also carries features like hallucinations or coma, as well as a variety of neurological deficits. Prevention of edema fluid formation with minimal side effects remains to be discovered. Endothelin-1 receptors were found to be involved in the pathogenesis of HACE. Due to the elevated level of Endothelin-1(ET-1), cerebral edema levels increase. In the present study, the authors have identified possible interactions of seven spirodihydro benzofuranlactam derivatives with the two endothelin-1 receptors A and B.

 

Keywords: HACE, endothelin, antagonists, edema

Cite this Article

Grace Ratna Roy, Shanmughavel P. Molecular interaction and simulation studies of inhibitors for endothelin-1 receptors. Research & Reviews: A Journal of Bioinformatics. 2015; 2(3): 15–26p.

Downloads

Published

2019-03-18

Issue

Vol. 2 No. 3 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.